Imagine you are conducting a buy-side analysis of a mid-sized, family-run pharmaceutical firm in India. As you review the management risks, you notice that the founder remains the sole decision-maker, yet there is no mention of a formal board-approved continuity plan. You immediately recognize a valuation discount is necessary; without clear legal mechanisms to transition both personal assets and operational control, the company faces existential risk upon a sudden leadership vacancy.
Distinguishing between estate planning and succession planning here is not just an academic exercise—it is critical to your assessment of the firm’s long-term enterprise value.
Estate planning is fundamentally an individual-centric process, primarily using instruments like Wills, Codicils, and Private Family Trusts to manage the distribution of personal wealth. In the Indian context, this often involves the application of personal laws such as the Indian Succession Act or the Hindu Succession Act to determine asset devolution. These tools are designed to facilitate the smooth, tax-efficient transfer of properties, financial investments, and personal belongings to heirs or intended beneficiaries.
When you evaluate an HNI’s portfolio, you are looking for the presence of these instruments to ensure that the asset base remains intact and isn’t eroded by probate litigation or unplanned tax liabilities.
Succession planning, conversely, is enterprise-focused and operates through a different set of legal levers such as Shareholders’ Agreements (SHA), Board Resolutions, and Management Buy-Sell Agreements. The goal here is business continuity, ensuring that operational authority, equity voting rights, and intellectual property remain stable even when a key stakeholder departs.
For a closely-held Indian private limited company, this may involve complex cross-holding structures or tiered equity arrangements that define who succeeds to the CEO position or who has the right of first refusal on share transfers. Mixing these tools—for example, attempting to govern corporate control through a simple Will rather than a formal SHA—often leads to debilitating boardroom gridlock.
Consider the contrast between a Will and an SHA. A Will is a revocable, unilateral document that takes effect only upon death, making it poor for real-time operational governance. A Shareholders’ Agreement, however, is a bilateral or multilateral contract that binds current and future owners, providing immediate, enforceable rules for decision-making and exit strategies. An analyst failing to discern this difference may inaccurately price the ‘key person risk’ of a company, erroneously assuming that a founder’s personal Will covers the transition of business control, which it almost certainly does not.
Nuance
Check Your Understanding
An analyst reviews a company where the founder has included a clause in their Will specifying which family member will become the new CEO. Why should the analyst view this as a potential governance risk?
Which of the following scenarios best reflects the primary function of a Private Family Trust in the context of estate planning?
This is a companion read for Section 14.1 — Estate Planning from PASS Investment Adviser (Level 2) by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.